06 December 2024
06 December 2024
Dewpoint is set to obtain an upfront payment and is eligible for milestone payments that could total $480m.
Muna will receive an upfront payment of $35.2m from GSK.
The FDA has granted accelerated approval to Bizengri in the treatment of advanced, unresectable NG1+ lung and pancreatic cancers.
The combination therapy involves Artiva’s AlloNK (AB101) and Affimed’s acimtamig (AFM13).
Insights from studies of centenarians are shedding light on how to live longer, healthier lives.
The decision was based on the positive outcomes of the Phase III programme.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
